Skip to main content

Featured

Interparfums FY 2022: record earnings as operating profit soars 33 percent

THE WHAT? Interparfums has reported its results for the 2022 fiscal year. The fragrance giant recorded record earnings for the full year with net income up 40 percent on 2021’s figures and sales rising 26 percent to €706.6 million. THE DETAILS The company noted that it had extended its partnership with Montblanc until December 31, 2030 and, subject to the General Meeting’s ratification, hit its goal of achieving gender parity on its board. THE WHY? Philippe Benacin, Chairman and CEO, commented, “Against the backdrop of a turbulent economic and geopolitical environment, our sales and earnings continued to grow in 2022. In 2023, although many uncertainties still exist, this positive momentum should continue with sales expected to reach €750 million, driven by the continuing appeal of our brands for consumers in a global perfume market that remains buoyant.” The post Interparfums FY 2022: record earnings as operating profit soars 33 percent appeared first on Global Cosme

Recall Alert: Three Major Baby Formula Brands Are Contaminated With Salmonella

Recall Alert: Three Major Baby Formula Brands Are Contaminated With Salmonella

When we’ve chatted about recalls in the past, it’s usually because E. Coli was discovered in ground beef or listeria was found in spinach. But today’s recall is both more concerning and much more urgent because it affects our littlest loved ones. The Food and Drug Administration (FDA) has just announced that Abbott Nutrition has issued a voluntary recall of Similac, Alimentum, and EleCare powdered infant formulas due to complaints of Cronobacter sakazakii and Salmonella, which are two types of bacteria that tend to grow and thrive in dry food. So far, at least four infants in three different states including Minnesota, Oregon, and Texas have been sickened after consuming one of the three powdered formulas. The FDA believes that one of the infants may have died due to cronobacter contamination.

“As this is a product used as the sole source of nutrition for many of our nation’s newborns and infants, the FDA is deeply concerned about these reports of bacterial infections,” said Frank Yiannas, FDA Deputy Commissioner for Food Policy and Response, in a statement. “We want to reassure the public that we’re working diligently with our partners to investigate complaints related to these products, which we recognize include infant formula produced at this facility, while we work to resolve this safety concern as quickly as possible.”

Read More >>



* This article was originally published here

Comments

Popular Posts